- Home
- RZLT vs HRTX Comparison
RZLT vs HRTX Comparison
Compare RZLT & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- HRTX
- Stock Information
- Founded
- RZLT 2010
- HRTX 1983
- Country
- RZLT United States
- HRTX United States
- Employees
- RZLT N/A
- HRTX N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- RZLT Health Care
- HRTX Health Care
- Exchange
- RZLT Nasdaq
- HRTX Nasdaq
- Market Cap
- RZLT 226.4M
- HRTX 270.7M
- IPO Year
- RZLT N/A
- HRTX 1987
- Fundamental
- Price
- RZLT $3.05
- HRTX $2.38
- Analyst Decision
- RZLT Strong Buy
- HRTX Strong Buy
- Analyst Count
- RZLT 8
- HRTX 3
- Target Price
- RZLT $12.00
- HRTX $5.67
- AVG Volume (30 Days)
- RZLT 482.0K
- HRTX 2.7M
- Earning Date
- RZLT 05-14-2025
- HRTX 05-06-2025
- Dividend Yield
- RZLT N/A
- HRTX N/A
- EPS Growth
- RZLT N/A
- HRTX N/A
- EPS
- RZLT N/A
- HRTX N/A
- Revenue
- RZLT N/A
- HRTX $144,285,000.00
- Revenue This Year
- RZLT N/A
- HRTX $11.81
- Revenue Next Year
- RZLT N/A
- HRTX $15.79
- P/E Ratio
- RZLT N/A
- HRTX N/A
- Revenue Growth
- RZLT N/A
- HRTX 13.57
- 52 Week Low
- RZLT $1.76
- HRTX $1.04
- 52 Week High
- RZLT $6.19
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- RZLT 24.55
- HRTX 58.92
- Support Level
- RZLT $3.25
- HRTX $2.29
- Resistance Level
- RZLT $3.81
- HRTX $2.56
- Average True Range (ATR)
- RZLT 0.22
- HRTX 0.20
- MACD
- RZLT -0.05
- HRTX -0.01
- Stochastic Oscillator
- RZLT 4.35
- HRTX 46.43
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.